Journal
FRONTIERS IN ENDOCRINOLOGY
Volume 11, Issue -, Pages -Publisher
FRONTIERS MEDIA SA
DOI: 10.3389/fendo.2020.616766
Keywords
anovulatory disorders; polycystic ovary syndrome; amenorrhea; anti-Mü llerian hormone; premature ovarian insufficiency
Categories
Ask authors/readers for more resources
This review discusses the role of anti-mullerian hormone (AMH) in the differential diagnosis of anovulatory disorders, focusing on its value in predicting the severity of the disease. Current limitations and potential future clinical applications are also addressed.
Since the historical use of gonadotrophin and estradiol levels to define the different anovulatory disorders has shown some limitations, the use of other markers such as anti-mullerian hormone (AMH) has been proposed. This review addresses the role of AMH in the differential diagnosis of anovulatory disorders, especially focusing on its value in the prognostic characterization of their severity. Current limitations and future clinical applications are discussed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
